Evofosfamide combined with gemcitabine/nab-paclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial

Journal article

Peer reviewed

Mitesh J. Borad, Eunice Lee Kwak, Andrea Wang-Gillam, Ayman Ibrahim, Julie Aldridge and Anthony J. Olszanski

Journal of clinical oncology, Vol.34(15_suppl), pp.4114-4114

20/05/2016

Abstract

Abstract only

1 Record Views

Title: Evofosfamide combined with gemcitabine/nab-paclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial
Creators - without role: Mitesh J. Borad - Mayo Clinic in Arizona
Eunice Lee Kwak - Massachusetts General Hospital
Andrea Wang-Gillam - Washington University in St. Louis
Ayman Ibrahim - Ono Pharmaceutical
Julie Aldridge - Ono Pharmaceutical
Anthony J. Olszanski - Fox Chase Cancer Center
Publication Details: Journal of clinical oncology, Vol.34(15_suppl), pp.4114-4114
Identifiers: 9921872508331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article